Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
40 /100
COMPONENT-LIMITED
Score updated Aug 28, 2026

HQL — Abrdn Life Sciences Investors Dilution Risk Tracker

Track HQL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track HQL — Get alerts when the score changes →

As of August 28, 2026, Abrdn Life Sciences Investors (HQL) has a DilutionWatch DilutionScore of 40/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Abrdn Life Sciences Investors has a market capitalization of $543.09M, 30.41M shares outstanding, 87 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊Float Risk
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for HQL.
🔔 Track HQL — Get forecast alerts →

Market Data

Market Cap$543.09M
Shares Outstanding30.41M
FloatN/A
Cash$75.5K
DebtN/A
Short InterestN/A

Institutional Holdings

QoQ: ↑ 15.2% shares (2026Q1 vs prior)
87 institutional holders · 10.56M shares
#1 MORGAN STANLEY 3.61M shares
#2 Saba Capital Management, L.P. 947.3K shares
#3 Penserra Capital Management LLC 806.9K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest18.4K
Days to Cover1.0
% of FloatN/A
FINRA data as of Jul 31, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news
Track HQL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking HQL — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for HQL
HQL FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.